CBD Nutraceuticals Market to Grow with a CAGR of 12.43% through 2031
Increasing consumer awareness and a desire for natural
wellness solutions is expected to drive the Global CBD Nutraceuticals Market
growth in the forecast period, 2027-2031
According to TechSci Research report, “CBD
Nutraceuticals Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2031”, the Global CBD Nutraceuticals Market will grow from USD 5.09 Billion in 2025 to USD 10.28 Billion by 2031 at a 12.43% CAGR. This can be attributed to investment and
competition. The rapid growth of the CBD nutraceuticals market has attracted
significant investment from both established companies and startups. This
influx of capital has fueled innovation, research and development, and the
creation of new brands and products. The resulting competition has driven
improvements in product quality and formulation.
Furthermore, collaboration between CBD nutraceutical
companies and traditional healthcare providers is on the rise. Doctors and
healthcare practitioners are becoming more open to integrating CBD into patient
treatment plans, leading to potential partnerships that can help legitimize CBD
as a wellness solution.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global CBD
Nutraceuticals Market”
The growth in the market is being propelled by several
key factors, including the increasing preference among consumers for
plant-based supplements, growing awareness of the medical benefits of
cannabidiol, the legalization of hemp-derived CBD products in various
countries, and an improvement in the standard of living.
Numerous nutraceutical companies are entering the CBD
sector, offering a diverse range of supplements and functional foods in various
forms. For instance, MGC Pharma has introduced a range of nutraceutical
products, including CBD capsules, water-soluble CBD solutions, and hemp powder, in
the Chinese market. These products have rapidly gained popularity among
consumers due to their ability to provide the medical benefits of cannabidiol
without causing intoxication. The intensifying competition in the CBD nutraceuticals
industry is prompting companies to launch new products and expand their
presence in different regions. For example, in April 2019, Aphria Inc. entered
the German market by introducing its first line of cannabidiol-based
nutraceutical products called CannRelief. In the same month, Australian
biopharmaceutical firm MGC Pharmaceuticals partnered with the Chinese
e-commerce platform YuShop Global to enter the Chinese CBD nutraceuticals
market. This heightened competition is expected to drive market growth.
Furthermore, the rising demand for hemp protein among
athletes, bodybuilders, and the vegan population is expected further to boost the CBD nutraceuticals market during the forecast period. Hemp protein
powder, a high-quality plant-based protein, contains twenty amino acids and is
easily digestible by the human body. It also has a higher dietary fiber content
compared to soy protein or rice protein, making it a preferred choice among
consumers who are increasingly conscious of the key ingredients in dietary
supplements.
However, the presence of alternatives like herbal
nutraceuticals, including Garcinia Cambogia, raspberry ketones, echinacea, and
turmeric, which have traditionally dominated the global nutraceuticals market,
is hindering the growth of the CBD nutraceuticals market. Additionally, new
entrants face challenges in navigating the CBD nutraceutical space, and
existing players encounter difficulties in launching new products due to the
complex and inconsistent regulatory frameworks in different countries.
The Global CBD Nutraceuticals Market is segmented into
product type, distribution channel, regional distribution, and company
By product type, CBD tinctures accounted for the largest share of the global CBD nutraceuticals market in 2022. The
increasing adoption of CBD tinctures can be attributed to their superior
bioavailability compared to oils, making them highly effective in alleviating
severe pain, anxiety, stress, and other ailments. This heightened demand is a
key driving factor. Furthermore, the availability of CBD tinctures in various
volumes and concentrations tailored to individual needs is expected to drive further growth in this segment over the projected period.
Conversely, the capsules and soft gels category is
expected to experience the most rapid growth over the forecast period.
This growth can be attributed to the convenience and travel-friendliness of
these products. Additionally, many users find the taste and texture of
tinctures unappealing, making them less suitable for daily consumption.
Consequently, there is a shift toward capsules and soft gels, which are easy to ingest and provide premeasured doses.
Based on distribution channel, the retail store sales
channel emerged as the dominant force in the market in 2022. The primary driver of this segment's growth is the increasing collaboration between manufacturers and retailers to expand their distribution networks. For
instance, in September 2019, CV Sciences, Inc. entered into a distribution partnership with The Vitamin Shoppe, enabling sales of its products across 383 stores in the United States. In October 2019, the company expanded its distribution network, now serving its products through 515 Vitamin Shoppe stores.
Conversely, the online sales channel is expected to
experience the most rapid growth in the forecasted period. Companies operating
in the CBD nutraceuticals sector are striving to make their products available
through all sales channels, with particular emphasis on online
platforms to reach remote areas. These channels offer comprehensive product
information, quality certifications, ingredient details, and dosage
instructions to consumers, which serve as compelling attractions for this
sales channel. All of these factors are poised to propel the growth of this
segment in the years to come.
Major companies operating in Global CBD
Nutraceuticals Market are:
- Gaia Botanicals LLC
- CV Sciences, Inc.
- Elixinol LLC
- Garden of Life
- Isodiol International Inc
- Medical Marijuana Inc
- Medterra
Download
Free Sample Report
Customers can also request for 10% free customization
on this report
“The global CBD nutraceuticals market is poised for
continued growth and innovation, driven by the emergence of the key trends. As
the industry matures, consumers can expect to see a wider range of products,
greater transparency, and more rigorous quality control. As research into CBD's
health benefits advances and regulatory clarity improves, the market is
well-positioned to provide consumers with safe, effective, and customized CBD
nutraceutical solutions for various wellness needs,” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“CBD Nutraceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, and By Competition 2021-2031F”, has evaluated
the future growth potential of Global CBD Nutraceuticals Market and provides
statistics & information on market size, structure and future market
growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global CBD Nutraceuticals Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com